TRAF2 overexpression also enhanced the ability of osteotropic breast cancer cells and their derived factors to induce osteoclast formation, inhibit osteoblast differentiation and to cause osteolysis by a mechanism that depends at least in part on NFκB activation. Here, NFKB1 is linked to breast cancer.